Bone Density May Signal Cognitive Decline Risk, Study Suggests

Researchers have found a potential link between bone density and the rate of cognitive decline, suggesting that routine CT scans could offer an early indicator of brain health.

The study, which analyzed data from individuals who underwent non-contrast CT scans of the chest, multimodal brain MRIs, and cognitive testing, revealed that lower bone density was associated with accelerated decline in three key areas related to brain function.

Specifically, the research found that reduced bone density in the spine correlated with a greater decline in the integrity of white matter fibers, particularly in brain regions responsible for cognition and executive functions such as planning and emotional regulation. White matter, composed of millions of nerve fibers, facilitates communication between different brain areas and naturally degrades with age, a process linked to vascular dementia, Alzheimer's disease, and stroke-inducing small vessel disease.

Furthermore, the study indicated that lower bone density was associated with a more rapid accumulation of white matter hyperintensities. These appear as bright spots on MRI scans and signify damaged or abnormal white matter, commonly seen with aging and connected to impaired cognitive function and increased dementia risk.

The cognitive testing component of the research also showed that individuals with lower bone density experienced a faster decline in cognitive abilities, including memory, attention, and information processing speed.

This research suggests that bone density, measurable through CT scans that are often performed for other medical reasons like lung cancer screening or calcium scoring, could serve as an opportunistic marker for broader biological aging processes that may also affect the brain. The authors emphasize that lower bone density does not directly cause cognitive decline but may indicate underlying shared mechanisms such as inflammation, metabolic dysfunction, or vascular problems affecting both bone and brain health.

Identifying individuals at risk for accelerated cognitive decline earlier could allow for timely interventions. Addressing controllable risk factors like physical inactivity, high blood pressure, and diabetes, along with closer monitoring, may help manage cognitive aging. Additionally, for those who develop conditions like Alzheimer's disease, early diagnosis is crucial, especially with the advent of new medications that can slow disease progression in its early stages.